| Views | |
|---|---|
| Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies | 501 |
| October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies | 4 | 8 | 5 | 6 | 6 | 18 | 3 |
| Views | |
|---|---|
| Dissertation_P.Mehlitz_2016.pdf | 282 |
